<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Babesiosis: Clinical manifestations and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Babesiosis: Clinical manifestations and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Babesiosis: Clinical manifestations and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter J Krause, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edouard G Vannier, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Johanna Daily, MD, MSc</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Babesiosis is an infectious disease caused by protozoa of the genus <em>Babesia</em> that infect and lyse red blood cells. <em>Babesia</em> spp are transmitted primarily by tick vectors after their acquisition from small mammal reservoir hosts. Transmission occasionally occurs through blood transfusion and rarely through organ transplantation or congenitally. <em>Babesia</em> protozoa infect mammals and cause lysis of host red blood cells [<a href="#rid1">1-5</a>].</p><p><em>Babesia microti</em> is the primary agent of human babesiosis in the United States, particularly in the Northeast and upper Midwest where it is endemic. Nearly all cases in Europe have been attributed to <em>Babesia divergens</em>,<em> </em>but the infection is sporadic. <em>Babesia venatorum</em> and <em>Babesia crassa</em>-like infections are endemic in northeastern China.</p><p>The clinical manifestations and diagnosis of babesiosis will be reviewed here. The treatment, prevention, microbiology, epidemiology, and pathogenesis of babesiosis are discussed separately. (See  <a class="medical medical_review" href="/d/html/5734.html" rel="external">"Babesiosis: Microbiology, epidemiology, and pathogenesis"</a> and  <a class="medical medical_review" href="/d/html/113483.html" rel="external">"Babesiosis: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span><em>Babesia</em> infections range from asymptomatic to severe and sometimes are fatal. The severity of infection depends on the <em>Babesia</em> species and the immune status of the host.</p><p class="headingAnchor" id="H3"><span class="h2">Infection due to B. microti</span><span class="headingEndMark"> — </span><em>B. microti</em> is the predominant species that infects humans in the United States. <em>B. microti</em> also causes disease in Asia, Australia, Central America, and Europe [<a href="#rid1">1-5</a>]. Clinical manifestations may be absent or range from mild to severe.</p><p>The incubation period of <em>B. microti</em> infection following a tick bite typically is one to four weeks; the incubation period after transfusion of contaminated blood products usually is three to seven weeks but ranges from one week to six months [<a href="#rid2">2,5,6</a>].</p><p>Clinical manifestations of babesiosis may develop in individuals with subclinical infection who undergo splenectomy for a medical condition other than babesiosis or who develop an immunosuppressive condition such as malignancy [<a href="#rid7">7-9</a>].</p><p class="headingAnchor" id="H3224541652"><span class="h3">Asymptomatic infection</span><span class="headingEndMark"> — </span>The discrepancy between seroprevalence and the prevalence of clinical disease suggests that asymptomatic infection is common. One cohort study on Block Island, Rhode Island (a highly endemic area) identified asymptomatic <em>B. microti</em> infection in 40 percent of children and 20 percent of adults [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/d/html/5734.html" rel="external">"Babesiosis: Microbiology, epidemiology, and pathogenesis", section on 'Incidence and prevalence'</a>.)</p><p class="headingAnchor" id="H4"><span class="h3">Mild to moderate disease</span><span class="headingEndMark"> — </span>Mild to moderate babesiosis typically occurs in immunocompetent patients and is associated with a parasitemia less than 4 percent.</p><p>Patients with mild to moderate disease usually experience gradual onset of fatigue and malaise accompanied by fever. Fever (&gt;38°C) is intermittent or sustained and has been described as high as 40.9°C (105.6°F). Fever, fatigue, and malaise may be accompanied by one or more of the following [<a href="#rid2">2,5,11-14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Common: chills, sweats, and myalgia</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Less common: anorexia, headache, nausea, and dry cough</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Least common: arthralgia, shortness of breath, sore throat, neck stiffness, emotional lability, abdominal pain, vomiting, diarrhea, dark urine, conjunctival injection, photophobia, hyperesthesia, and weight loss</p><p></p><p>On physical examination, fever is the salient feature. Splenomegaly and/or hepatomegaly may be noted [<a href="#rid11">11,14,15</a>]. Uncommon physical findings include scleral icterus, jaundice, mild pharyngeal erythema, and retinopathy with splinter hemorrhages with or without retinal infarcts [<a href="#rid5">5</a>]. Lymphadenopathy is absent.</p><p>Rash is seldom associated with babesiosis; if an erythematous rash is observed, concurrent Lyme disease should be suspected. (See <a class="local">'Coinfection with other tick-borne illnesses'</a> below.)</p><p>Laboratory abnormalities associated with mild to moderate babesiosis include low hematocrit, low hemoglobin, elevated lactate dehydrogenase, low haptoglobin, and/or reticulocytosis [<a href="#rid5">5</a>]. Thrombocytopenia is common. The white blood cell count is normal, increased, or decreased; neutropenia may occur [<a href="#rid16">16</a>]. Liver enzymes are sometimes elevated, including alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase. Total and indirect bilirubin, blood urea nitrogen, and/or serum creatinine levels may be elevated.</p><p class="headingAnchor" id="H3664024961"><span class="h3">Severe disease</span><span class="headingEndMark"> — </span>Severe babesiosis often occurs in older and/or immunocompromised patients and is associated with parasitemia ≥4 percent (although it can occur with parasitemia &lt;4 percent). Severe babesiosis may also lead to complications, including persistent or relapsing disease [<a href="#rid11">11,14,15</a>]. (See <a class="local">'Complications'</a> below and <a class="local">'Relapse'</a> below.)</p><p>Risk factors for severe babesiosis include age &gt;50, neonatal prematurity, asplenia, malignancy, HIV infection, and immunosuppressive drugs. These are discussed further separately. (See  <a class="medical medical_review" href="/d/html/5734.html" rel="external">"Babesiosis: Microbiology, epidemiology, and pathogenesis", section on 'Risk factors'</a>.)</p><p>Clinical manifestations of severe disease are similar to those of mild to moderate disease but more intense. Nausea or vomiting and diarrhea are predictive of severe infection [<a href="#rid15">15</a>]. (See <a class="local">'Mild to moderate disease'</a> above.)</p><p>Laboratory test abnormalities associated with severe babesiosis are the same as those for mild to moderate babesiosis, but more frequent, more pronounced, and of longer duration [<a href="#rid5">5</a>].</p><p>Radiographic findings associated with severe babesiosis may include pulmonary edema on chest radiograph and splenic infarct and/or splenic rupture on abdominal computed tomography scan [<a href="#rid11">11,14</a>].</p><p class="headingAnchor" id="H671996899"><span class="h3">Complications</span><span class="headingEndMark"> — </span>Complications develop in nearly half of patients hospitalized with babesiosis [<a href="#rid2">2</a>]. The most common complication is acute respiratory distress syndrome (ARDS). In one series including 22 patients with severe babesiosis requiring intensive care, the mortality rate was higher among patients who developed ARDS than among those who did not (37 versus 14 percent) [<a href="#rid17">17</a>]. Among those who developed ARDS, survivors were younger (survivors mean age 54 years; nonsurvivors mean age 74 years) and had a lower Sequential Organ Failure Assessment (SOFA) score (mean score 6.0 versus 12.3). </p><p>Other complications include severe anemia, congestive heart failure, renal failure, disseminated intravascular coagulation, shock, and coma [<a href="#rid11">11,14</a>]. Such complications are strongly associated with severe anemia (hemoglobin &lt;10 g/dL) and, to a lesser degree, with high-grade parasitemia (≥10 percent) [<a href="#rid11">11</a>]. </p><p>Splenic rupture is a rare complication. It typically occurs in otherwise healthy individuals who tend to be younger [<a href="#rid4">4,18,19</a>]. Splenic rupture is spontaneous (ie, nontraumatic) and is thought to result from excessive erythrophagocytosis in the red pulp. Intense abdominal pain is the chief complain. Most patients with splenic rupture present with mild splenomegaly, have low parasitemia, and do not present with other complications typically associated with severe babesiosis [<a href="#rid8">8,18-21</a>].</p><p>Warm autoimmune hemolytic anemia has been described as a late complication of babesiosis in asplenic individuals two to four weeks after symptoms and parasitemia have resolved [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/d/html/7078.html" rel="external">"Warm autoimmune hemolytic anemia (AIHA) in adults"</a>.)</p><p>The fatality rate has ranged from 3 to 9 percent in hospitalized patients and is approximately 20 percent among those who are highly immunosuppressed or have acquired the disease through blood transfusion [<a href="#rid11">11,14,23</a>].</p><p class="headingAnchor" id="H2296940815"><span class="h3">Relapse</span><span class="headingEndMark"> — </span>Relapsing babesiosis (despite a standard course of antimicrobial therapy) typically occurs in highly immunocompromised patients with probable impairment of <em>Babesia</em> antibody production. These include patients with B cell lymphoma or other conditions treated with <a class="drug drug_general" data-topicid="9616" href="/d/drug information/9616.html" rel="external">rituximab</a>, patients with malignancy who also are asplenic, patients with organ or stem cell transplantation, and patients with HIV/AIDS [<a href="#rid23">23-26</a>]. (See  <a class="medical medical_review" href="/d/html/5734.html" rel="external">"Babesiosis: Microbiology, epidemiology, and pathogenesis", section on 'Risk factors'</a>.)</p><p>Relapse usually occurs within a few days or a week after discontinuation of antibiotics, but the interval can be longer. Confirmation that symptoms are due to relapse is best made by detection of the parasite on thin blood smear. (See <a class="local">'Microscopy'</a> below and  <a class="medical medical_review" href="/d/html/113483.html" rel="external">"Babesiosis: Treatment and prevention", section on 'Immunocompromised patients'</a>.)</p><p>Relapsing episodes of babesiosis tend to be less severe than the initial episode of infection, in part because diagnosis is made earlier. Relapse of illness, however, has had a fatal outcome in about one-fifth of cases [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H2169671147"><span class="h3">Coinfection with other tick-borne illnesses</span><span class="headingEndMark"> — </span>Other pathogens transmitted by <em>Ixodes scapularis</em> ticks include <em>Borrelia burgdorferi</em>, <em>Anaplasma phagocytophilum</em>, <em>Borrelia miyamotoi</em>, <em>Borrelia mayonii</em>, Powassan virus, and <em>Ehrlichia muris–</em>like agent. One or more of these pathogens can cause coinfection along with <em>B. microti</em> or with other <em>Babesia</em> spp. (See  <a class="medical medical_review" href="/d/html/7914.html" rel="external">"Diagnosis of Lyme disease"</a> and  <a class="medical medical_review" href="/d/html/7907.html" rel="external">"Human ehrlichiosis and anaplasmosis"</a> and  <a class="medical medical_review" href="/d/html/101368.html" rel="external">"Borrelia miyamotoi infection"</a> and  <a class="medical medical_review" href="/d/html/1293.html" rel="external">"Arthropod-borne encephalitides", section on 'Powassan virus'</a>.)</p><p>Approximately one-half of patients with babesiosis experience concurrent Lyme disease. The incidence of coinfection depends on a number of variables, especially geographic location [<a href="#rid15">15,27</a>].Patients with Lyme disease and concurrent babesiosis may experience a greater number of acute symptoms for a longer duration than patients with Lyme disease alone [<a href="#rid12">12,28</a>]. In one study, concurrent Lyme disease had no effect on the severity of babesiosis [<a href="#rid12">12</a>]; in another study, the number and duration of symptoms in patients with babesiosis and Lyme disease were lower than in patients with babesiosis alone [<a href="#rid28">28</a>].</p><p>Patients who have been diagnosed with an <em>Ixodes</em>-borne infection should be evaluated for coinfection with pathogens that are endemic in the region. (See  <a class="medical medical_review" href="/d/html/7914.html" rel="external">"Diagnosis of Lyme disease"</a> and  <a class="medical medical_review" href="/d/html/7907.html" rel="external">"Human ehrlichiosis and anaplasmosis"</a>.)</p><p class="headingAnchor" id="H4251902445"><span class="h2">Infection due to other species</span><span class="headingEndMark"> — </span>The epidemiology of infection due to other <em>Babesia</em> species is discussed separately. (See  <a class="medical medical_review" href="/d/html/5734.html" rel="external">"Babesiosis: Microbiology, epidemiology, and pathogenesis", section on 'Epidemiology'</a>.)</p><p class="headingAnchor" id="H1235512341"><span class="h3">B. divergens</span><span class="headingEndMark"> — </span><em>B. divergens</em> is the predominant <em>Babesia</em> species in Europe. Infection with <em>B. divergens</em> should be suspected when residents of areas where <em>B. divergens</em> has previously been reported or travelers from these areas present with symptoms consistent with babesiosis, particularly in the setting of asplenia. Nearly all symptomatic cases attributed to <em>B. divergens</em> have been reported in asplenic individuals, although at least two asymptomatic cases in immunocompetent people have been documented [<a href="#rid29">29-31</a>].</p><p>Symptoms of <em>B. divergens</em> infection usually appear abruptly following an incubation period of one to three weeks. The presenting symptoms are persistent high fever (&gt;41°C), shaking chills, intense sweats, headache, myalgia, and lumbar and abdominal pain. Dark urine and jaundice indicate severe intravascular hemolysis. On physical examination, mild hepatomegaly may be noted. Characteristic abnormal laboratory findings include low hemoglobin levels (4 to 8 g/dL) and high parasitemia, which can be as high as 80 percent [<a href="#rid29">29</a>]. Until exchange transfusion became an adjunctive therapy, <em>B. divergens</em> infection often was fatal despite antimicrobial therapy.</p><p class="headingAnchor" id="H7"><span class="h3">B. divergens-like organisms</span><span class="headingEndMark"> — </span>Cases of infection due to <em>B. divergens</em>–like organisms have been documented in the Midwest (Arkansas, Kentucky, Michigan, Missouri) and in Washington state [<a href="#rid32">32-34</a>]. All patients were &gt;50 years and asplenic. Clinical manifestations and abnormal laboratory findings are similar to those reported for <em>B. divergens</em> and other <em>Babesia </em>spp. Peak parasitemia ranged from 15 to 41 percent. Three of the six patients died despite medical intervention.</p><p class="headingAnchor" id="H8"><span class="h3">B. duncani and related organisms</span><span class="headingEndMark"> — </span>A small number of infections (&lt;15) due to <em>Babesia duncani</em> and related organisms have been described on the West Coast of the United States. Cases range in severity from asymptomatic to fatal. Clinical manifestations are similar to those of <em>B. microti</em> infection, including fever, weakness, malaise, fatigue, chills, sweats, headache, myalgia, arthralgia, nausea, vomiting, anorexia, weight loss, and dark urine. Laboratory findings may include low hematocrit, thrombocytopenia, hyperbilirubinemia, and elevated liver enzymes.</p><p>Five symptomatic patients with tick-borne <em>B. duncani</em> infection have been documented. All were men, and four were asplenic [<a href="#rid35">35,36</a>]. Three asplenic men survived, but the fourth died. One of the surviving patients had severe disease including disseminated coagulation, pulmonary edema, and renal insufficiency but recovered with antibiotic therapy [<a href="#rid35">35,36</a>].</p><p>Three cases of transfusion-acquired <em>B. duncani</em> infections have been described [<a href="#rid37">37-39</a>]. The first case occurred in a 76-year-old normosplenic man. The second case was a premature male neonate who developed respiratory distress. The third case was a 59-year-old patient with sickle cell anemia and other comorbidities who required intensive care for severe anemia and acute renal failure. All three patients had severe illness but recovered with antibiotic therapy with or without exchange transfusion.</p><p class="headingAnchor" id="H9"><span class="h3">B. venatorum</span><span class="headingEndMark"> — </span>Cases of <em>B. venatorum</em> initially were described in Europe. All five cases occurred in asplenic men aged &gt;50 years. One patient experienced mild symptoms, including fatigue and dark urine. Another patient presented with weakness, shortness of breath, and lethargy. The other three patients experienced severe disease and were admitted to the hospital. Abnormal laboratory findings were those reported for other <em>Babesia spp</em>. Parasitemia ranged from 1 to 30 percent. In one case, massive hemolysis required blood transfusion. In all five cases, symptoms resolved with antibiotic therapy, and parasitemia eventually cleared [<a href="#rid40">40-42</a>].</p><p>Cases of<em> B. venatorum</em> have been reported from mainland China [<a href="#rid43">43,44</a>]. The initial case report was an eight-year-old normosplenic boy with prolonged intermittent fever (38.6 to 41°C), shortness of breath, fatigue, malaise, and progressive weakness [<a href="#rid43">43</a>]. Laboratory tests demonstrated hemolytic anemia, thrombocytopenia, leukocytosis, and elevated bilirubin and lactate dehydrogenase. Symptoms abated within three days of therapy and parasitemia eventually cleared. Subsequently, a series of 48 cases with <em>B. venatorum</em> infection occurring over four years were reported in northeastern China [<a href="#rid44">44</a>]. Two-thirds of individuals were symptomatic and all had a spleen. Patients presented with fever (66 percent), fatigue (44 percent), headache (41 percent), and myalgia or arthralgia (38 percent), but chills were experienced less often (9 percent) than among patients infected with <em>B. microti</em> in the United States (67 percent). No deaths were reported.</p><p class="headingAnchor" id="H3189621441"><span class="h3">B. crassa-like organisms</span><span class="headingEndMark"> — </span>A series of 58 cases of babesiosis caused by <em>B. crassa</em> was reported from northeastern China [<a href="#rid45">45</a>]. All subjects had a spleen and two-thirds were female. Among the 31 confirmed cases, age at infection ranged from 29 to 72 years. The infection was mild to moderate. Fever was less frequent than among patients infected with <em>B. microti</em> (48 versus &gt;80 percent) but headache was more frequent (74 versus approximately 40 percent). Nausea and vomiting were noted among one-half of patients (52 percent). Laboratory findings included elevated total or indirect bilirubin (32 percent) and elevated liver enzymes (16 percent).  </p><p class="headingAnchor" id="H10"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H3199346265"><span class="h2">Clinical approach</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical suspicion</strong> – The diagnosis of babesiosis should be suspected in the following circumstances:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with typical clinical manifestations (fever, fatigue, chills, sweats, myalgia, anorexia, headache, nausea, and dry cough) and typical laboratory test abnormalities (hemolytic anemia, thrombocytopenia, and/or elevation of aminotransferases) in the setting of relevant epidemiologic exposure (eg, residents of endemic areas, travelers returning from endemic areas, or blood transfusion in the previous six months).</p><p></p><p class="bulletIndent2">Most infections with <em>B. microti </em>are acquired by tick bite between May and September; three-fourths of cases are diagnosed from June through August. Transfusion-transmitted babesiosis may be acquired throughout the year. (See  <a class="medical medical_review" href="/d/html/5734.html" rel="external">"Babesiosis: Microbiology, epidemiology, and pathogenesis", section on 'Transmission'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with Lyme disease, human granulocytic anaplasmosis, or other <em>Ixodes</em>-borne infections may be coinfected with <em>Babesia </em>spp because the causative agents of these infections are transmitted by the same<em> Ixodes</em> tick vector. (See <a class="local">'Coinfection with other tick-borne illnesses'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic tools</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Use of microscopy and PCR</strong> – Preferred tools for diagnosis of babesiosis include blood smear for identification of <em>Babesia</em> organisms and polymerase chain reaction (PCR) for detection of <em>Babesia</em> DNA [<a href="#rid1">1</a>]. (See <a class="local">'Microscopy'</a> below and <a class="local">'Polymerase chain reaction'</a> below.)</p><p></p><p class="bulletIndent2">Diagnostic evaluation for babesiosis should begin with evaluation of a thin blood smear, which has a rapid turn-around time and allows quantification of parasitemia but requires microscopy expertise (<a class="graphic graphic_algorithm graphicRef114552" href="/d/graphic/114552.html" rel="external">algorithm 1</a> and <a class="graphic graphic_picture graphicRef131054" href="/d/graphic/131054.html" rel="external">picture 1</a>). If microscopy expertise is not available, PCR testing should be pursued. This tool has a longer turn-around time (up to a few days) but is more sensitive than microscopy and therefore is useful when parasitemia is very low. In addition, PCR can distinguish between <em>Babesia</em> species. </p><p></p><p class="bulletIndent2">If symptoms persist but microscopy has been negative, repeat blood smear examination and/or PCR testing should be performed. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Serology</strong> – Positive serology (a fourfold rise in <em>Babesia imm</em>unoglobulin [Ig]G antibody titers in acute and convalescent sera) is of limited use for the diagnosis of acute disease but provides retrospective confirmation of <em>Babesia infe</em>ction [<a href="#rid5">5</a>]. (See <a class="local">'Serology'</a> below.)</p><p></p><p class="bulletIndent2">Serology may be a useful adjunct to blood smear and PCR [<a href="#rid4">4,5,46</a>]. For patients with a positive <em>Babesia </em>antibody test, diagnostic confirmation with blood smear or PCR should be pursued; a single positive antibody test is not sufficient to establish a diagnosis because <em>Babesia </em>antibodies can persist in blood for a year or more following apparent clearance of infection, with or without treatment [<a href="#rid1">1</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation for other tick-borne illnesses – </strong>Patients with babesiosis an <em>Ixodes</em>-borne infection should be evaluated for coinfection with other locally endemic <em>Ixodes</em>-borne pathogens endemic in the region. (See <a class="local">'Coinfection with other tick-borne illnesses'</a> above and  <a class="medical medical_review" href="/d/html/7914.html" rel="external">"Diagnosis of Lyme disease"</a> and  <a class="medical medical_review" href="/d/html/7907.html" rel="external">"Human ehrlichiosis and anaplasmosis"</a>.)</p><p></p><p class="headingAnchor" id="H2084020789"><span class="h2">Laboratory diagnostic tools</span><span class="headingEndMark"> — </span>Tools for diagnosis of babesiosis include microscopy, PCR, and serology.</p><p class="headingAnchor" id="H11"><span class="h3">Microscopy</span><span class="headingEndMark"> — </span>The diagnosis of babesiosis can be established by identification of <em>Babesia </em>organisms on thin blood smears (Wright or Giemsa staining under oil immersion). Thick blood smears can be difficult to interpret and should be performed only by an experienced microscopist [<a href="#rid2">2,5,47</a>]. The United States Centers for Disease Control and Prevention (CDC) can review blood smears that are difficult to interpret.</p><p>Microscopic diagnosis of babesiosis requires time and expertise. At least 200 to 300 microscopic fields should be reviewed before concluding that there is no parasitemia. In the setting of very low parasitemia (particularly at the onset of symptoms), the diagnosis of babesiosis may require examination of multiple smears over several days. Automated cell readers should not be used to detect <em>Babesia</em> spp in red blood cells, as they do not reliably detect ring forms and merozoites.</p><p><em>B. microti</em> trophozoites are round, oval, or pear-shaped and have a blue cytoplasm with red chromatin dots (<a class="graphic graphic_picture graphicRef131054" href="/d/graphic/131054.html" rel="external">picture 1</a>). Multiple infections per cell may be observed. Ring forms are most common and may resemble the rings of <em>Plasmodium falciparum</em>. Babesiosis may be distinguished from malaria by the presence of merozoites arranged in tetrads (known as a "Maltese Cross"; this finding is uncommon but pathognomonic for babesiosis), presence of extracellular forms, absence of hemozoin deposit (appears as brownish pigment) in ring forms, and absence of gametocytes. Examples of <em>Babesia</em> spp on blood smears are provided on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fdpdx%2Fbabesiosis%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLFx4sxRuubQ2m%2BZMa9CcUtrWQF0y7gSdL4uy2yv9N0srdzhkc0sckcBE5j%2Fr0KS9Og%3D%3D&amp;TOPIC_ID=5670" target="_blank">CDC website</a>.</p><p><em>B. duncani</em> trophozoites are indistinguishable from those of <em>B. microti</em>; tetrads of <em>B. duncani</em> merozoites are observed more commonly than tetrads of <em>B. microti</em> [<a href="#rid48">48</a>].<em> B. divergens</em>, <em>B. divergens</em>–like organisms, and <em>B. venatorum</em> are round or pear-shaped; they are typically arranged in pairs but can appear as tetrads in human erythrocytes [<a href="#rid29">29,32-34,49</a>].</p><p>Diagnosis of babesiosis via microscopy should prompt estimation of parasite density. This can be done by examining a monolayer of red blood cells (RBCs) using the oil immersion objective at 100x. (See  <a class="medical medical_review" href="/d/html/5707.html" rel="external">"Laboratory tools for diagnosis of malaria"</a>.)</p><p>The level of parasitemia is generally between 0.1 and 10 percent but has been as high as 80 percent [<a href="#rid2">2</a>]. Mild to moderate babesiosis is associated with parasitemia &lt;4 percent; severe babesiosis is associated with parasitemia ≥4 percent [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H12"><span class="h3">Polymerase chain reaction</span><span class="headingEndMark"> — </span>Diagnosis of babesiosis can be established using PCR-based amplification of <em>Babesia </em>DNA. PCR is especially useful in the setting of low-level parasitemia (eg, in asymptomatic carriers, at the onset of symptoms, or during convalescence). It also enables species identification and parasite quantification [<a href="#rid2">2,9,50</a>].</p><p>Real-time PCR assays target the <em>Babesia</em> 18S rRNA gene and have 100 percent specificity [<a href="#rid50">50-54</a>]. The limit of detection has ranged from 0.07 to 10 parasites/microliter of blood [<a href="#rid50">50-53</a>]. Additional steps (a freeze-thaw cycle to rupture erythrocytes and high-speed centrifugation to pellet free parasites) can reduce the limit of detection to 7 parasites per liter of blood [<a href="#rid55">55</a>].</p><p>Parasite DNA may be detectable by PCR for several months following completion of antibiotic therapy and resolution of symptoms [<a href="#rid9">9</a>]. In untreated asymptomatic individuals, <em>Babesia</em> DNA has been detected as long as 404 days [<a href="#rid56">56</a>]. Persistence of DNA may be as long as 26 months in the setting of immunosuppression [<a href="#rid9">9,57</a>].</p><p class="headingAnchor" id="H13"><span class="h3">Serology</span><span class="headingEndMark"> — </span>Serology may be used for diagnostic confirmation of babesiosis and species identification [<a href="#rid58">58</a>]. Serology should be interpreted with caution because onset of symptoms sometimes precedes the rise in antibody titer and because antibody may persist beyond resolution of infection, making it difficult to distinguish current from recent or past infection [<a href="#rid2">2,29,46</a>].</p><p>The antigen used for serologic testing should be that of the suspected <em>Babesia</em> species. Indirect fluorescent antibody testing (IFAT) is the most common serologic test. A standardized IFAT to detect <em>B. microti</em>–specific IgG is available through the CDC [<a href="#rid59">59-61</a>]. The IFAT also is offered by commercial diagnostic laboratories. The IFAT that uses whole <em>B. microti</em> antigen has a sensitivity of 88 to 96 percent and a specificity of 90 to 100 percent [<a href="#rid60">60</a>]. Enzyme-linked immunosorbent assay (ELISA) and Western blot assays have been developed but are not routinely used for the diagnosis of acute babesiosis [<a href="#rid59">59,61</a>].</p><p>A fourfold rise in <em>Babesia</em> IgG titer in acute and convalescent sera confirms recent infection; a single positive antibody titer seldom can distinguish current from recent or past infection. The antibody titer that defines the threshold for a positive serologic test for a particular species can differ between laboratories. During the acute phase of illness, <em>B. microti</em> IgG titers usually exceed 1:1024 but typically decline to ≤1:64 within 6 to 12 months [<a href="#rid9">9</a>]. IgM antibody is usually detected two weeks after onset of illness. A positive IgM titer is suggestive of recent infection but must be accompanied by a positive IgG titer to establish a diagnosis [<a href="#rid2">2,59</a>]. The correlation between antibody titers and symptoms is poor [<a href="#rid62">62</a>].</p><p>Serology also is useful for blood donor screening to prevent transfusion-transmitted babesiosis [<a href="#rid5">5</a>]. This is discussed further separately. (See  <a class="medical medical_review" href="/d/html/7946.html" rel="external">"Blood donor screening: Laboratory testing", section on 'Babesia microti'</a>.)</p><p>Assays for <em>B. microti</em> antibody do not detect <em>B. divergens</em>, <em>B. duncani</em>, or <em>B. venatorum</em> antibody. Cross-reactivity has been observed between <em>B. divergens</em> and <em>B. divergens</em>–like organisms and between <em>B. divergens</em> and <em>B. venatorum </em>[<a href="#rid33">33,34,63</a>]. There have been too few cases of <em>B. duncani</em> infection to validate an indirect fluorescent antibody test for this organism. Sera from individuals exposed to <em>Babesia</em> spp can weakly cross-react with <em>Plasmodium</em> antigen when tested at lower dilutions [<a href="#rid47">47,64</a>].</p><p class="headingAnchor" id="H3576456908"><span class="h2">Radiographic studies</span><span class="headingEndMark"> — </span>Patients with respiratory symptoms should undergo chest radiography to evaluate for pulmonary edema and/or other findings consistent with acute respiratory distress syndrome. In the rare event that a patient with babesiosis and left upper quadrant tenderness is suspected of having splenic infarction and/or splenic rupture, an abdominal computed tomography should be considered. (See <a class="local">'Complications'</a> above.)</p><p class="headingAnchor" id="H8942404"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of babesiosis includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Malaria – Malaria is characterized by fever and anemia. Clinical manifestations mirror those of babesiosis and include fatigue, headache, arthralgia, myalgia, and nausea. The diagnosis of malaria should be suspected in the setting of relevant epidemiologic exposure and is established by visualization of parasites on peripheral smear or use of a rapid diagnostic test. Babesiosis may be distinguished from malaria on thin blood smear by the presence of merozoites arranged in tetrads (known as a "Maltese Cross"; this finding is uncommon but pathognomonic for babesiosis), absence of hemozoin deposit (appears as brownish pigment) in ring forms, and absence of gametocytes. (See <a class="local">'Microscopy'</a> above and  <a class="medical medical_review" href="/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"</a> and  <a class="medical medical_review" href="/d/html/5707.html" rel="external">"Laboratory tools for diagnosis of malaria"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other infections transmitted by <em>Ixodes</em> ticks – Etiologic agents include <em>Anaplasma phagocytophilum</em>, <em>Borrelia burgdorferi, Borrelia mayonii, Borrelia miyamotoi</em>, <em>Ehrlichia muris</em>–like infection, and Powassan virus. The clinical manifestations of these diseases are often similar to those of babesiosis and include fever, malaise, headache, myalgia, and arthralgia. Distinguishing features that are not found with babesiosis include erythema migrans rash (<em>B. burgdorferi</em>), relapsing fever (<em>B. miyamotoi</em>), and encephalitis (Powassan virus). Laboratory features shared by several of these infections include thrombocytopenia and elevated transaminases. The diagnosis of these diseases is established by microscopy, polymerase chain reaction, and/or serology. (See <a class="local">'Coinfection with other tick-borne illnesses'</a> above and  <a class="medical medical_review" href="/d/html/7907.html" rel="external">"Human ehrlichiosis and anaplasmosis"</a> and  <a class="medical medical_review" href="/d/html/101368.html" rel="external">"Borrelia miyamotoi infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rickettsioses – Patient with rickettsial infection typically present with fever, headache, thrombocytopenia, leukopenia, and transaminase elevation. Petechial rash and/or eschar may develop after several days of illness. (See  <a class="medical medical_review" href="/d/html/7904.html" rel="external">"Clinical manifestations and diagnosis of Rocky Mountain spotted fever"</a> and  <a class="medical medical_review" href="/d/html/7908.html" rel="external">"Other spotted fever group rickettsial infections"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Leptospirosis – Leptospirosis is a bacterial infection characterized by fever, myalgia, headache, and conjunctival suffusion. Modest elevation of hepatic transaminases may be observed. The diagnosis is established by serology. (See  <a class="medical medical_review" href="/d/html/5527.html" rel="external">"Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Viral hepatitis (hepatitis A, B, C, D, and E) – These entities are characterized by elevated transaminases. Hepatitis A and E are acute infections transmitted by the fecal-oral route whereas hepatitis B, C, and D can present acutely or chronically and are transmitted by body fluids. (See related topics.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bacteremia – Meningococcal, pneumococcal, and staphylococcal bacteremia may be associated with fulminant anemia, thrombocytopenia, hepatic abnormalities, disseminated intravascular coagulation, and acute respiratory distress syndrome. The diagnosis is established by identification of the pathogen on culture. (See related topics.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Noninfectious causes of hemolytic anemia – Noninfectious causes of hemolytic anemia are summarized in the table (<a class="graphic graphic_table graphicRef72394" href="/d/graphic/72394.html" rel="external">table 1</a>). Clinical manifestations include pallor, jaundice, and splenomegaly. (See  <a class="medical medical_review" href="/d/html/7076.html" rel="external">"Diagnosis of hemolytic anemia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>HELLP (hemolysis, elevated liver enzymes, and low platelet count) – In pregnant women, babesiosis may be confused with the HELLP syndrome [<a href="#rid65">65</a>]. The diagnosis of HELLP is established via laboratory criteria. (See  <a class="medical medical_review" href="/d/html/6778.html" rel="external">"HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets)"</a>.)</p><p></p><p class="headingAnchor" id="H587505118"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/111579.html" rel="external">"Society guideline links: Tick-borne infections (Lyme disease, ehrlichiosis, anaplasmosis, babesiosis, and Rocky Mountain spotted fever)"</a>.)</p><p class="headingAnchor" id="H33"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – <em>Babesia</em> infections range from asymptomatic to severe and are sometimes fatal. The severity of infection depends on the species and the immune status of the host.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong><em>Babesia microti</em></strong> –<strong> </strong><em>B. microti</em> is the predominant species in the United States. The incubation period of <em>B. microti </em>infection following a tick bite typically is one to four weeks; the incubation period after transfusion of contaminated blood products typically is three to seven weeks but can be up to six months. (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Infection due to B. microti'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Mild to moderate disease</strong> – Mild to moderate <em>B. microti</em> infection typically occurs in immunocompetent patients and is associated with parasitemia &lt;4 percent. Patients usually experience gradual onset of fatigue and malaise accompanied by fever. Other common symptoms include chills, sweats, myalgia, anorexia, headache, nausea, and dry cough. Laboratory abnormalities include low hematocrit, low hemoglobin, elevated lactate dehydrogenase, low haptoglobin, reticulocytosis, thrombocytopenia, elevated liver enzymes, and elevated creatinine. (See <a class="local">'Mild to moderate disease'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Severe disease</strong> – Severe <em>B. microti</em> infection often occurs in immunocompromised patients and is associated with parasitemia ≥4 percent (although it can occur with parasitemia &lt;4 percent). It may also be associated with complications including persistent or relapsing disease. Symptoms and laboratory abnormalities are similar to those seen with mild to moderate babesiosis but more pronounced. Complications include acute respiratory distress syndrome, congestive heart failure, renal failure, disseminated intravascular coagulation, shock, splenic rupture, and coma. (See <a class="local">'Severe disease'</a> above and <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Risk factors for severe disease</strong> – Risk factors for severe <em>B. microti</em> infection include age &gt;50, neonatal prematurity, asplenia, malignancy, HIV infection, and immunosuppressive drugs. Relapsing babesiosis (despite a standard course of antimicrobial therapy) typically occurs in highly immunocompromised patients with impaired <em>Babesia</em> antibody production. These include patients with B cell lymphoma or other conditions treated with <a class="drug drug_general" data-topicid="9616" href="/d/drug information/9616.html" rel="external">rituximab</a>, patients with malignancy who also are asplenic, patients with organ or stem cell transplantation, and patients with HIV/AIDS. (See <a class="local">'Severe disease'</a> above and <a class="local">'Relapse'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong><em>Babesia divergens</em></strong><em> – B. divergens</em> is the predominant species in Europe. Nearly all symptomatic cases attributed to <em>B. divergens</em> are severe and occur in asplenic individuals. Disease caused by <em>Babesia venatorum</em> has ranged from mild in immunocompetent individuals (mainland China) to severe in immunocompromised patients (Europe). (See <a class="local">'Infection due to other species'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical suspicion</strong> – The diagnosis of babesiosis should be suspected in patients with typical clinical manifestations and laboratory features in the setting of relevant epidemiologic exposure (eg, residents of endemic areas, travelers returning from endemic areas, or blood transfusion in the previous six months). (See <a class="local">'Clinical approach'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical approach</strong> – Diagnostic evaluation for babesiosis should begin with evaluation of thin blood smear(s), which has a rapid turn-around time but requires microscopy expertise (<a class="graphic graphic_algorithm graphicRef114552" href="/d/graphic/114552.html" rel="external">algorithm 1</a> and <a class="graphic graphic_picture graphicRef131054" href="/d/graphic/131054.html" rel="external">picture 1</a>). PCR is particularly useful when parasitemia is low and can distinguish among <em>Babesia</em> species. If symptoms persist but microscopy has been negative, repeat blood smear examination should be performed in conjunction with PCR testing. In the absence of microscopy expertise, PCR testing should be performed. Both smear and PCR allow quantification of parasitemia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Coinfection</strong> – Patients with babesiosis an <em>Ixodes</em>-borne infection should be evaluated for coinfection with other locally endemic <em>Ixodes</em>-borne pathogens endemic in the region. (See <a class="local">'Clinical approach'</a> above and <a class="local">'Coinfection with other tick-borne illnesses'</a> above.)</p><p></p><p class="headingAnchor" id="H403107842"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Jeffrey A Gelfand, MD, FACP, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Krause PJ, Auwaerter PG, Bannuru RR, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clin Infect Dis 2021; 72:185.</a></li><li><a class="nounderline abstract_t">Vannier E, Krause PJ. Human babesiosis. N Engl J Med 2012; 366:2397.</a></li><li><a class="nounderline abstract_t">Krause PJ. Human babesiosis. Int J Parasitol 2019; 49:165.</a></li><li><a class="nounderline abstract_t">Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review. JAMA 2016; 315:1767.</a></li><li><a class="nounderline abstract_t">Vannier EG, Diuk-Wasser MA, Ben Mamoun C, Krause PJ. Babesiosis. Infect Dis Clin North Am 2015; 29:357.</a></li><li><a class="nounderline abstract_t">Herwaldt BL, Linden JV, Bosserman E, et al. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011; 155:509.</a></li><li><a class="nounderline abstract_t">Semel ME, Tavakkolizadeh A, Gates JD. Babesiosis in the immediate postoperative period after splenectomy for trauma. Surg Infect (Larchmt) 2009; 10:553.</a></li><li><a class="nounderline abstract_t">Wormser GP, Lombardo G, Silverblatt F, et al. Babesiosis as a cause of fever in patients undergoing a splenectomy. Am Surg 2011; 77:345.</a></li><li><a class="nounderline abstract_t">Krause PJ, Spielman A, Telford SR 3rd, et al. Persistent parasitemia after acute babesiosis. N Engl J Med 1998; 339:160.</a></li><li><a class="nounderline abstract_t">Krause PJ, McKay K, Gadbaw J, et al. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg 2003; 68:431.</a></li><li><a class="nounderline abstract_t">Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001; 32:1117.</a></li><li><a class="nounderline abstract_t">Krause PJ, Telford SR 3rd, Spielman A, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA 1996; 275:1657.</a></li><li><a class="nounderline abstract_t">Reubush TK 2nd, Cassaday PB, Marsh HJ, et al. Human babesiosis on Nantucket Island. Clinical features. Ann Intern Med 1977; 86:6.</a></li><li><a class="nounderline abstract_t">White DJ, Talarico J, Chang HG, et al. Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998; 158:2149.</a></li><li><a class="nounderline abstract_t">Mareedu N, Schotthoefer AM, Tompkins J, et al. Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis. Am J Trop Med Hyg 2017; 97:1218.</a></li><li><a class="nounderline abstract_t">Wormser GP, Villafuerte P, Nolan SM, et al. Neutropenia in Congenital and Adult Babesiosis. Am J Clin Pathol 2015; 144:94.</a></li><li><a class="nounderline abstract_t">Alvarez De Leon S, Srivastava P, Revelo AE, et al. Babesiosis as a cause of acute respiratory distress syndrome: a series of eight cases. Postgrad Med 2019; 131:138.</a></li><li><a class="nounderline abstract_t">Dumic I, Patel J, Hart M, et al. Splenic Rupture as the First Manifestation of Babesia Microti Infection: Report of a Case and Review of Literature. Am J Case Rep 2018; 19:335.</a></li><li><a class="nounderline abstract_t">Li S, Goyal B, Cooper JD, et al. Splenic rupture from babesiosis, an emerging concern? A systematic review of current literature. Ticks Tick Borne Dis 2018; 9:1377.</a></li><li><a class="nounderline abstract_t">Farber FR, Muehlenbachs A, Robey TE. Atraumatic splenic rupture from Babesia: A disease of the otherwise healthy patient. Ticks Tick Borne Dis 2015; 6:649.</a></li><li><a class="nounderline abstract_t">Patel KM, Johnson JE, Reece R, Mermel LA. Babesiosis-associated Splenic Rupture: Case Series From a Hyperendemic Region. Clin Infect Dis 2019; 69:1212.</a></li><li><a class="nounderline abstract_t">Woolley AE, Montgomery MW, Savage WJ, et al. Post-Babesiosis Warm Autoimmune Hemolytic Anemia. N Engl J Med 2017; 376:939.</a></li><li><a class="nounderline abstract_t">Krause PJ, Gewurz BE, Hill D, et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis 2008; 46:370.</a></li><li><a class="nounderline abstract_t">Stowell CP, Gelfand JA, Shepard JA, Kratz A. Case records of the Massachusetts General Hospital. Case 17-2007. A 25-year-old woman with relapsing fevers and recent onset of dyspnea. N Engl J Med 2007; 356:2313.</a></li><li><a class="nounderline abstract_t">Falagas ME, Klempner MS. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis 1996; 22:809.</a></li><li><a class="nounderline abstract_t">Wormser GP, Prasad A, Neuhaus E, et al. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Clin Infect Dis 2010; 50:381.</a></li><li><a class="nounderline abstract_t">Diuk-Wasser MA, Vannier E, Krause PJ. Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences. Trends Parasitol 2016; 32:30.</a></li><li><a class="nounderline abstract_t">Krause PJ, McKay K, Thompson CA, et al. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin Infect Dis 2002; 34:1184.</a></li><li><a class="nounderline abstract_t">Zintl A, Mulcahy G, Skerrett HE, et al. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev 2003; 16:622.</a></li><li><a class="nounderline abstract_t">Gorenflot A, Moubri K, Precigout E, et al. Human babesiosis. Ann Trop Med Parasitol 1998; 92:489.</a></li><li><a class="nounderline abstract_t">Martinot M, Zadeh MM, Hansmann Y, et al. Babesiosis in immunocompetent patients, Europe. Emerg Infect Dis 2011; 17:114.</a></li><li><a class="nounderline abstract_t">Beattie JF, Michelson ML, Holman PJ. Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N Engl J Med 2002; 347:697.</a></li><li><a class="nounderline abstract_t">Herwaldt B, Persing DH, Précigout EA, et al. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med 1996; 124:643.</a></li><li><a class="nounderline abstract_t">Herwaldt BL, de Bruyn G, Pieniazek NJ, et al. Babesia divergens-like infection, Washington State. Emerg Infect Dis 2004; 10:622.</a></li><li><a class="nounderline abstract_t">Persing DH, Herwaldt BL, Glaser C, et al. Infection with a babesia-like organism in northern California. N Engl J Med 1995; 332:298.</a></li><li><a class="nounderline abstract_t">Quick RE, Herwaldt BL, Thomford JW, et al. Babesiosis in Washington State: a new species of Babesia? Ann Intern Med 1993; 119:284.</a></li><li><a class="nounderline abstract_t">Herwaldt BL, Kjemtrup AM, Conrad PA, et al. Transfusion-transmitted babesiosis in Washington State: first reported case caused by a WA1-type parasite. J Infect Dis 1997; 175:1259.</a></li><li><a class="nounderline abstract_t">Kjemtrup AM, Lee B, Fritz CL, et al. Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California. Transfusion 2002; 42:1482.</a></li><li><a class="nounderline abstract_t">Bloch EM, Herwaldt BL, Leiby DA, et al. The third described case of transfusion-transmitted Babesia duncani. Transfusion 2012; 52:1517.</a></li><li><a class="nounderline abstract_t">Häselbarth K, Tenter AM, Brade V, et al. First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen. Int J Med Microbiol 2007; 297:197.</a></li><li><a class="nounderline abstract_t">Herwaldt BL, Cacciò S, Gherlinzoni F, et al. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis 2003; 9:942.</a></li><li><a class="nounderline abstract_t">Blum S, Gattringer R, Haschke E, et al. The case: hemolysis and acute renal failure. Babesiosis. Kidney Int 2011; 80:681.</a></li><li><a class="nounderline abstract_t">Sun Y, Li SG, Jiang JF, et al. Babesia venatorum Infection in Child, China. Emerg Infect Dis 2014; 20:896.</a></li><li><a class="nounderline abstract_t">Jiang JF, Zheng YC, Jiang RR, et al. Epidemiological, clinical, and laboratory characteristics of 48 cases of "Babesia venatorum" infection in China: a descriptive study. Lancet Infect Dis 2015; 15:196.</a></li><li><a class="nounderline abstract_t">Jia N, Zheng YC, Jiang JF, et al. Human Babesiosis Caused by a Babesia crassa-Like Pathogen: A Case Series. Clin Infect Dis 2018; 67:1110.</a></li><li><a class="nounderline abstract_t">Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis 2021; 72:e1.</a></li><li><a class="nounderline abstract_t">Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitol 2000; 30:1323.</a></li><li><a class="nounderline abstract_t">Conrad PA, Kjemtrup AM, Carreno RA, et al. Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol 2006; 36:779.</a></li><li><a class="nounderline abstract_t">Holman PJ. Phylogenetic and biologic evidence that Babesia divergens is not endemic in the United States. Ann N Y Acad Sci 2006; 1081:518.</a></li><li><a class="nounderline abstract_t">Wang G, Villafuerte P, Zhuge J, et al. Comparison of a quantitative PCR assay with peripheral blood smear examination for detection and quantitation of Babesia microti infection in humans. Diagn Microbiol Infect Dis 2015; 82:109.</a></li><li><a class="nounderline abstract_t">Teal AE, Habura A, Ennis J, et al. A new real-time PCR assay for improved detection of the parasite Babesia microti. J Clin Microbiol 2012; 50:903.</a></li><li><a class="nounderline abstract_t">Rollend L, Bent SJ, Krause PJ, et al. Quantitative PCR for detection of Babesia microti in Ixodes scapularis ticks and in human blood. Vector Borne Zoonotic Dis 2013; 13:784.</a></li><li><a class="nounderline abstract_t">Moritz ED, Winton CS, Johnson ST, et al. Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States. Transfusion 2014; 54:2226.</a></li><li><a class="nounderline abstract_t">Wilson M, Glaser KC, Adams-Fish D, et al. Development of droplet digital PCR for the detection of Babesia microti and Babesia duncani. Exp Parasitol 2015; 149:24.</a></li><li><a class="nounderline abstract_t">Bloch EM, Lee TH, Krause PJ, et al. Development of a real-time polymerase chain reaction assay for sensitive detection and quantitation of Babesia microti infection. Transfusion 2013; 53:2299.</a></li><li><a class="nounderline abstract_t">Bloch EM, Levin AE, Williamson PC, et al. A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors. Transfusion 2016; 56:1875.</a></li><li><a class="nounderline abstract_t">Raffalli J, Wormser GP. Persistence of babesiosis for &gt;2 years in a patient on rituximab for rheumatoid arthritis. Diagn Microbiol Infect Dis 2016; 85:231.</a></li><li><a class="nounderline abstract_t">Leiby DA, Johnson ST, Won KY, et al. A longitudinal study of Babesia microti infection in seropositive blood donors. Transfusion 2014; 54:2217.</a></li><li><a class="nounderline abstract_t">Krause PJ, Ryan R, Telford S 3rd, et al. Efficacy of immunoglobulin M serodiagnostic test for rapid diagnosis of acute babesiosis. J Clin Microbiol 1996; 34:2014.</a></li><li><a class="nounderline abstract_t">Krause PJ, Telford SR 3rd, Ryan R, et al. Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis 1994; 169:923.</a></li><li><a class="nounderline abstract_t">Levin AE, Williamson PC, Erwin JL, et al. Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion 2014; 54:2237.</a></li><li><a class="nounderline abstract_t">Ruebush TK 2nd, Chisholm ES, Sulzer AJ, Healy GR. Development and persistence of antibody in persons infected with Babesia microti. Am J Trop Med Hyg 1981; 30:291.</a></li><li><a class="nounderline abstract_t">Duh D, Jelovsek M, Avsic-Zupanc T. Evaluation of an indirect fluorescence immunoassay for the detection of serum antibodies against Babesia divergens in humans. Parasitology 2007; 134:179.</a></li><li><a class="nounderline abstract_t">Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int J Parasitol 2008; 38:1219.</a></li><li><a class="nounderline abstract_t">Gulersen M, Brost BC, Bobrovnikov V, Bornstein E. Acute Babesiosis in Pregnancy: A Novel Imitator of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome. Obstet Gynecol 2016; 128:197.</a></li></ol></div><div id="topicVersionRevision">Topic 5670 Version 42.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33501959" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22716978" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Human babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30690090" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Human babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27115378" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25999229" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21893613" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Transfusion-associated babesiosis in the United States: a description of cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19622029" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Babesiosis in the immediate postoperative period after splenectomy for trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21375849" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Babesiosis as a cause of fever in patients undergoing a splenectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9664092" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Persistent parasitemia after acute babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12875292" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Increasing health burden of human babesiosis in endemic sites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11283800" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Severe babesiosis in Long Island: review of 34 cases and their complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8637139" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/556920" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Human babesiosis on Nantucket Island. Clinical features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9801183" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28722598" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26071466" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Neutropenia in Congenital and Adult Babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30585748" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Babesiosis as a cause of acute respiratory distress syndrome: a series of eight cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29567936" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Splenic Rupture as the First Manifestation of Babesia Microti Infection: Report of a Case and Review of Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29954722" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Splenic rupture from babesiosis, an emerging concern? A systematic review of current literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26123434" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Atraumatic splenic rupture from Babesia: A disease of the otherwise healthy patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30541016" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Babesiosis-associated Splenic Rupture: Case Series From a Hyperendemic Region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28273010" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Post-Babesiosis Warm Autoimmune Hemolytic Anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18181735" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Persistent and relapsing babesiosis in immunocompromised patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17538091" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Case records of the Massachusetts General Hospital. Case 17-2007. A 25-year-old woman with relapsing fevers and recent onset of dyspnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8722936" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20047477" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26613664" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11941544" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14557289" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9683900" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Human babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21192869" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Babesiosis in immunocompetent patients, Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12200568" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Acute babesiosis caused by Babesia divergens in a resident of Kentucky.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8607592" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15200851" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Babesia divergens-like infection, Washington State.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7816065" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Infection with a babesia-like organism in northern California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8328736" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Babesiosis in Washington State: a new species of Babesia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9129100" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Transfusion-transmitted babesiosis in Washington State: first reported case caused by a WA1-type parasite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12421222" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22168221" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The third described case of transfusion-transmitted Babesia duncani.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17350888" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12967491" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21878956" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The case: hemolysis and acute renal failure. Babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24751126" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Babesia venatorum Infection in Child, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25539588" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Epidemiological, clinical, and laboratory characteristics of 48 cases of "Babesia venatorum" infection in China: a descriptive study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29538646" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Human Babesiosis Caused by a Babesia crassa-Like Pathogen: A Case Series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33417672" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11113258" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Human babesiosis: an emerging tick-borne disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16725142" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17135561" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Phylogenetic and biologic evidence that Babesia divergens is not endemic in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25861873" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Comparison of a quantitative PCR assay with peripheral blood smear examination for detection and quantitation of Babesia microti infection in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22170915" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : A new real-time PCR assay for improved detection of the parasite Babesia microti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24107203" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Quantitative PCR for detection of Babesia microti in Ixodes scapularis ticks and in human blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24865803" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25500215" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Development of droplet digital PCR for the detection of Babesia microti and Babesia duncani.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23362840" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Development of a real-time polymerase chain reaction assay for sensitive detection and quantitation of Babesia microti infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27184253" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27036977" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Persistence of babesiosis for&gt;2 years in a patient on rituximab for rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24673297" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : A longitudinal study of Babesia microti infection in seropositive blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8818902" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Efficacy of immunoglobulin M serodiagnostic test for rapid diagnosis of acute babesiosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8133112" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24995863" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7011069" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Development and persistence of antibody in persons infected with Babesia microti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17032478" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Evaluation of an indirect fluorescence immunoassay for the detection of serum antibodies against Babesia divergens in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18440005" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Babesiosis: recent insights into an ancient disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27275801" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Acute Babesiosis in Pregnancy: A Novel Imitator of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
